JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 93 filers reported holding JOUNCE THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.26 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $6,671 | +85.6% | 3,606 | +11.3% | 0.00% | – |
Q4 2022 | $3,595 | +259.5% | 3,239 | +944.8% | 0.00% | – |
Q3 2022 | $1,000 | 0.0% | 310 | +384.4% | 0.00% | – |
Q3 2020 | $1,000 | -99.6% | 64 | -99.8% | 0.00% | -100.0% |
Q2 2020 | $278,000 | +18.3% | 40,271 | -18.7% | 0.00% | 0.0% |
Q1 2020 | $235,000 | +840.0% | 49,555 | +1607.6% | 0.00% | – |
Q4 2019 | $25,000 | +1150.0% | 2,902 | +701.7% | 0.00% | – |
Q2 2019 | $2,000 | -90.0% | 362 | -88.6% | 0.00% | – |
Q1 2019 | $20,000 | -23.1% | 3,180 | -59.0% | 0.00% | – |
Q4 2018 | $26,000 | +100.0% | 7,754 | +289.6% | 0.00% | – |
Q3 2018 | $13,000 | +550.0% | 1,990 | +736.1% | 0.00% | – |
Q2 2018 | $2,000 | – | 238 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP II, LLC | 2,697,829 | $22,527,000 | 93.16% |
TRV GP III, LLC | 1,148,780 | $9,592,000 | 2.40% |
Deep Track Capital, LP | 4,000,000 | $33,400,000 | 2.36% |
Ally Bridge Group (NY) LLC | 575,000 | $4,801,000 | 1.68% |
Logos Global Management LP | 1,350,000 | $11,273,000 | 1.16% |
PFM Health Sciences, LP | 3,972,868 | $33,173,000 | 1.13% |
SILVERARC CAPITAL MANAGEMENT, LLC | 245,829 | $2,053,000 | 0.83% |
Yorktown Management & Research Co Inc | 137,300 | $1,146,000 | 0.77% |
Sofinnova Investments, Inc. | 1,582,777 | $13,216,000 | 0.77% |
ACUTA CAPITAL PARTNERS, LLC | 127,500 | $1,065,000 | 0.45% |